Clinical Trial Update: ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED) [Phase 4]

View source ↗

Summary

Completed Phase 4 study evaluating the renal protective effects of losartan in hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Organon and Co | Conditions: High Blood Pressure | Phase 4 | Status: COMPLETED